Accelrys, a provider of scientific innovation lifecycle management software and solutions, has announced the latest releases of Accelrys Insight and Accelrys Insight for Excel
Accelrys, a provider of scientific innovation lifecycle management solutions, has announced the release of Accelrys Notebook 5.0
Accelrys has announced the launch of ScienceCloud, a new SaaS-based information management and collaboration workspace that is used to advance collaborative drug discovery with new integrated applications built on a scalable, cloud-based scientific platform
Accelrys, a provider of scientific lifecycle management solutions, has announced the release of the Accelrys Materials Studio 7.0, a modelling and simulation environment for chemists, polymer scientists and other materials scientists
Accelrys has released the latest version of its unified biology assay and study management software suite, consisting of BioRails DM 4.5, BioRails PTO 4.5 and Morphit 3.0
Accelrys has announced the availability of an extensive set of advanced predictive sciences applications and services
Accelrys Insight and Accelrys Insight for Excel have been released, completing the roll-out of the company's next-generation cheminformatics suite and providing an interactive, collaborative environment for rapid and effective decision-making in drug discovery
Accelrys, a provider of scientific innovation lifecycle management (SILM) software, has launched its Enterprise Platform 9.0, an open, scientifically aware platform delivering breakthrough capabilities for managing big data and externalised research collaboration networks
Accelrys, a provider of scientific innovation lifecycle management software, has launched its Experiment Knowledge Base
Accelrys has launched its Externalized Collaboration Suite, a software solution designed specifically to address the needs of life sciences organisations engaged in externalised network research
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
